Tumor-associated overexpression of the soluble T1-S receptor in lymph node-negative breast cancer

Diagnostic Molecular Pathology

Volumn 9, Issue 1, 2000, Pages 26-34

  Werenskiold, Anne Katrin ^a   Prechtel, Dieter ^b   Harbeck, Nadia ^b   Höfler, Heinz ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Disease free survival; Interleukin 1 receptor; Metastasis; Neoplasm; Prognosis

Indexed keywords

RECEPTOR; T1 S RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA PRIMERS; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LYMPH NODES; LYMPHATIC METASTASIS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTEIN BIOSYNTHESIS; PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034104216     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200003000-00005     Document Type: Article

References (31)

1. Baessler R, Böcker W, Hermanek P. Die gegenwärtige Situation des Gradings beim Mammakarzinom. Pathologe 1992;13:130-4.
2. Bergers G, Reikerstorfer A, Braselmann S, Graninger P, Busslinger M. Alternative promoter usage of the fos-responsive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO J 1994; 13:1176-88.
3. Bianchi S, Calzolari A, Vezzosi V, et al. Lack of prognostic value of p53 protein expression in node-negative breast cancer. Tumori 1997;83:669-72.
4. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
5. Clark GM, McGuire W. Steroid receptors and other prognostic factors in primary breast cancer. Semin Oncol 1988;15:20-5.
6. DeMichele A, Weber BL. Recent advances in breast cancer biology. Curr Opin Oncol 1997;9:499-504.
7. Fearon ER, Vogelstein B. A genetic model for colorectal tumori-genesis. Cell 1990;61:759-67.
8. Hoskins K, Weber BL. Recent advances in breast cancer biology. Curr Opin Oncol 1995;7:495-9.
9. Iozzo R. Tumor stroma as a regulator of neoplastic behavior. Lab Invest 1995;73:157-60.
10. Isola J, Visakorpi T, Holli K, Kallioniemi OP. Association of overexpression of tumor suppressor protein p53 with rapid proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 1992;84:1109-14.
11. Kaufman DG, Arnold JT. Stromal-epithelial interactions in normal and neoplastic development. Cell Mol Pathogenesis 1996;403-32.
12. Klemenz R, Hoffmann S, Werenskiold AK. Serum- and oncoprotein mediated induction of a gene with similarity to carcinoembryonic antigen. Proc Natl Acad Sci USA 1989;86:5708-12.
13. Kumar S, Tzimas MN, Griswold DE, Young PR. Expression of ST2, an interleukin-1 receptor homolog, is induced by proinflammatory stimuli. Biochem Biophys Res Commun 1997;235:474-8.
14. Löhning M, Stroehmann A, Coyle A, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of IL-4-, IL-5, and IL-10 and important for Th2 effector function. Proc Natl Acad Sci U S A 1998;95:6930-6.
15. Porter PL, Malone KL, Heagerty PJ, et al. Expression of cell-cycle regulators p27kip1 and cyclinE, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 1997; 3:222-5.
16. Remmele W, Stegner HE. Immunhistochemischer Nachweis von Ostrogenrezeptoren (ER-ICA) im Mammakarzinomgewebe: Vorschlag zur einheitlichen Bewertung des Untersuchungsbefundes. Frauenarzt 1987;2:41-3.
17. Röβler U, Andres AC, Reichmann E, Schmahl W, Werenskiold AK. Expression of T1, a CEA family member, in mammary carcinomas of WAP-ras transgenic mice. Oncogene 1993;8:609-17.
18. Röβler U, Schmahl W, Werenskiold AK. Accumulation of trophoblast derived T1 protein in granulated metrial gland (GMG) cells of the pregnant mouse uterus. Electronical J Pathol 1995;1:952-1003.
19. Röβler U, Thomassen E, Hültner L, Baier S, Danescu J, Werenskiold AK. Secreted and membrane-bound isoforms of T1, an orphan receptor related to IL-1 binding proteins, are differently expressed in vivo. Dev Biol 1995;168:86-97.
20. Russo J, Russo IH. Mammary tumorigenensis. Prog Exp Tumor Res 1991;33:175-91.
21. Schmitt M, Thomssen C, Ulm K, et al. Time-varying prognostic impact of tumor biologic factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer. Br J Cancer 1997;76:306-11.
22. Silvestrini R, Benini E, Veneroni S, Daidone MG, Tomasic G, Salvadori B. p53 and bcl-2 expression correlates with clinical outcome in a series of node-negative breast cancer patients. J Clin Oncol 1996;14:1604-10.
23. Simpson JF, Page DL. Pathology of preinvasive and excellent-prognosis breast cancer. Curr Opin Oncol 1997;9:512-9.
24. Sobin LH, Fleming ID. TNM-classification of malignant tumors, 5th ed. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
25. Soong R, Iacopetta BJ, Harvey JM, Sterrett GF, Dawkins HJ, Hahnel R, Robbins PD. Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer. Int J Cancer 1997;74:642-7.
26. Thomassen E, Kothny G, Haas S, Danescu J, Hültner L, Dörmer P, Werenskiold AK. Role of celltype-specific promoters in the developmental regulation of T1, an Interleukin-1 receptor homologue. Cell Growth Differ 1995;6:178-84.
27. Tominaga S, Yokota T, Yanagisawa K, Tsukamoto T, Takagi T, Tetsuka T. Nucleotide sequence of a complementary DNA for human ST2. Biochim Biophys Acta 1992;1171:215-8.
28. Trueb T, Kalousek MB, Fröhli E, Klemenz R. Growth factor-mediated induction of the delayed early gene T1 depends on a 12-O-tetradecanoylphorbol 13-acetate-responsive element located 3.6kb upstream of the transcription initiation site. Proc Natl Acad Sci USA 1994;91:3896-900.
29. Werenskiold AK, Hoffmann S, Klemenz R. Induction of a mitogen responsive gene after the expression of the H-ras oncogene in NIH3T3 fibroblasts. Mol Cell Biol 1989;9:5207-14.
30. Xu D, Chan WL, Leung BP, et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med 1998;187:787-94.
31. Yanagisawa K, Takagi T, Tsukamoto T, Tetsuka T, Tominaga S. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 1993;318:83-7.